Cite
Immune-checkpoint inhibitor-mediated myocarditis: CTLA4, PD1 and LAG3 in the heart.
MLA
Munir, Amir Z., et al. “Immune-Checkpoint Inhibitor-Mediated Myocarditis: CTLA4, PD1 and LAG3 in the Heart.” Nature Reviews. Cancer, vol. 24, no. 8, Aug. 2024, pp. 540–53. EBSCOhost, https://doi.org/10.1038/s41568-024-00715-5.
APA
Munir, A. Z., Gutierrez, A., Qin, J., Lichtman, A. H., & Moslehi, J. J. (2024). Immune-checkpoint inhibitor-mediated myocarditis: CTLA4, PD1 and LAG3 in the heart. Nature Reviews. Cancer, 24(8), 540–553. https://doi.org/10.1038/s41568-024-00715-5
Chicago
Munir, Amir Z, Alan Gutierrez, Juan Qin, Andrew H Lichtman, and Javid J Moslehi. 2024. “Immune-Checkpoint Inhibitor-Mediated Myocarditis: CTLA4, PD1 and LAG3 in the Heart.” Nature Reviews. Cancer 24 (8): 540–53. doi:10.1038/s41568-024-00715-5.